Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Heart Failure
  Free Subscription

15.09.2025

1 Am Heart J
2 Am J Cardiol
1 Basic Res Cardiol
1 Circ Heart Fail
2 Clin Cardiol
4 Eur Heart J
14 Eur J Heart Fail
3 Int J Cardiol
2 J Am Coll Cardiol
2 J Card Fail
2 J Cardiol
1 J Cardiovasc Pharmacol
1 J Thorac Cardiovasc Surg
3 PLoS One


    Am Heart J

  1. GOLDENBERG I, Zareba W, Ezekowitz JA, Albert C, et al
    Rationale and Design of the Comparative Effectiveness of ICD Versus Non-ICD Therapy in Contemporary Heart Failure Patients at a Low Risk for Arrhythmic Death (CONTEMP-ICD) trial.
    Am Heart J. 2025 Sep 4:S0002-8703(25)00320-5. doi: 10.1016/j.ahj.2025.
    >> Share


    Am J Cardiol

  2. VACEK JL
    Climbing to the Summit of Guideline Directed Therapy of Heart Failure: A Slippery Slope.
    Am J Cardiol. 2025 Sep 6:S0002-9149(25)00540.
    >> Share

  3. TIAN F, Hu C, Liu W, Zhang B, et al
    Noninvasive Right Ventricular Myocardial Work by Pressure-Strain Loop: A New Perspective on Right Ventricular Function and Cardiac Resynchronization Therapy.
    Am J Cardiol. 2025;252:8-15.
    >> Share


    Basic Res Cardiol

  4. LI Z, Freiberg S, Music ML, Gu L, et al
    Cardiac sodium-glucose co-transporter 1 (SGLT1) contributes to heart failure in a mouse model of diabetic cardiomyopathy.
    Basic Res Cardiol. 2025 Sep 11. doi: 10.1007/s00395-025-01136.
    >> Share


    Circ Heart Fail

  5. REDDY YNV, Frantz RP, Hassoun PM, Hemnes A, et al
    Left Heart Abnormalities in Patients With Lung Disease, OSA, and Chronic Thromboemboli at Risk for or With Known Pulmonary Hypertension.
    Circ Heart Fail. 2025 May 29:e012912. doi: 10.1161/CIRCHEARTFAILURE.125.012912.
    >> Share


    Clin Cardiol

  6. TAHIR I, Shahbaz H, Khattak A
    "Bridging Guidelines and Real World Barriers: Reflections on GDMT Optimization in Heart Failure".
    Clin Cardiol. 2025;48:e70206.
    >> Share

  7. HIMRAL S, Sharma J, Sandal S, Mahajan K, et al
    SGLT2 Inhibitors and Sleep Quality in Heart Failure: Implications for Patient-Centered Outcomes.
    Clin Cardiol. 2025;48:e70208.
    >> Share


    Eur Heart J

  8. CREA F
    Myocarditis after COVID-19, sepsis-induced cardiomyopathy, and haemodynamic assessment of heart failure: focus on the myocardium.
    Eur Heart J. 2025;46:3315-3318.
    >> Share

  9. MENTE A, Miller V, Yusuf S
    Diet and heart failure: evidence is limited to make recommendations.
    Eur Heart J. 2025 Sep 9:ehaf521. doi: 10.1093.
    >> Share

  10. NEUEN BL, Vaduganathan M
    Glomerular filtration rate slope in heart failure: ready for prime time?
    Eur Heart J. 2025 Sep 9:ehaf643. doi: 10.1093.
    >> Share

  11. GOTTHARDT M
    RNA-binding proteins as therapeutic targets in cardiac fibrosis and heart failure.
    Eur Heart J. 2025 Sep 9:ehaf644. doi: 10.1093.
    >> Share


    Eur J Heart Fail

  12. NASSIRI S, Voordes GHD, Handoko ML, Voors AA, et al
    Reply to the letter regarding the article 'Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70038.
    >> Share

  13. BARAKAT MF, Amaral N, Brayson D, Amin-Youssef G, et al
    Ferric derisomaltose augments intrinsic skeletal muscle electron transport chain activity in heart failure: A FERRIC-HF II molecular substudy.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70028.
    >> Share

  14. OSTROMINSKI JW, Claggett BL, Desai AS, Jhund PS, et al
    Finerenone according to insulin resistance in heart failure: Insights from the FINEARTS-HF trial.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70034.
    >> Share

  15. ALMESNED MA, van Essen BJ, Voors AA, Lipsic E, et al
    Reply to the letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70044.
    >> Share

  16. CHANG HC, Gau SY
    Letter regarding the article 'Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70045.
    >> Share

  17. IVANOVSKI M, Mrak M, Meznar AZ, Jan M, et al
    The CONDUCT-AF trial: Rationale and design of a prospective, randomized, multicentre study comparing conduction system and biventricular pacing in patients undergoing atrioventricular node ablation for heart failure with atrial fibrillation.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70013.
    >> Share

  18. CAMPAIN J, Wakeham DJ, Dias K, MacNamara JP, et al
    Distinct blood volume and left ventricular adaptation to severe obesity in middle-aged adults at risk for heart failure.
    Eur J Heart Fail. 2025 Sep 9. doi: 10.1002/ejhf.70037.
    >> Share

  19. SHAH P, Bekfani T, Rubis P, Clark AL, et al
    Potential therapeutic effects of warming on patients with heart failure.
    Eur J Heart Fail. 2025 Sep 9. doi: 10.1002/ejhf.70011.
    >> Share

  20. BEER BN, Benson L, Basile C, Schrage B, et al
    Beta-blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes.
    Eur J Heart Fail. 2025 Sep 11. doi: 10.1002/ejhf.70046.
    >> Share

  21. KERAMIDA K, Lopez-Fernandez T, Anker MS, Petrie MC, et al
    Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology.
    Eur J Heart Fail. 2025 Sep 12. doi: 10.1002/ejhf.70005.
    >> Share

  22. YANG Z, Kou L, Liao S
    Letter regarding the article 'Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trial'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70039.
    >> Share

  23. ECHEVERRIA LE, Bocchi E, Demacq C, de Barros E Silva PGM, et al
    Sacubitril/valsartan versus enalapril in chronic Chagas cardiomyopathy with heart failure: Baseline characteristics of the PARACHUTE-HF trial.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70026.
    >> Share

  24. KEMPF T, Fuge J, Bauersachs J
    Reply to the letter regarding the article 'Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70029.
    >> Share

  25. SUN P
    Letter regarding the article 'Oral ferric maltol improves iron deficiency anaemia in patients with chronic heart failure'.
    Eur J Heart Fail. 2025 Sep 8. doi: 10.1002/ejhf.70024.
    >> Share


    Int J Cardiol

  26. RANA AM, Rafay MA, Amjad MW, Aslam MH, et al
    Critical appraisal of early diagnosis and progression to heart failure with preserved ejection fraction among hypertensive patients with left ventricular hypertrophy.
    Int J Cardiol. 2025 Sep 6:133877. doi: 10.1016/j.ijcard.2025.133877.
    >> Share

  27. UMAR M, Zaheer M, Gillani Z
    Letter to the Editor: Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
    Int J Cardiol. 2025 Sep 6:133871. doi: 10.1016/j.ijcard.2025.133871.
    >> Share

  28. CHEN X, Zhang Q, Bao Y
    Reconsidering thyroid hormone assessment in heart failure risk prediction.
    Int J Cardiol. 2025 Sep 8:133872. doi: 10.1016/j.ijcard.2025.133872.
    >> Share


    J Am Coll Cardiol

  29. RICCARDI M, Pagnesi M, Lombardi CM, Anker SD, et al
    Moderate Secondary Mitral Regurgitation: Evolving Evidence and Management Strategies.
    J Am Coll Cardiol. 2025;86:813-828.
    >> Share

  30. BLUMER V, Lindenfeld J, Lala A, Carson P, et al
    Let Us Call It Cardiogenic Preshock: A Working Definition From the Heart Failure Collaboratory.
    J Am Coll Cardiol. 2025;86:832-835.
    >> Share


    J Card Fail

  31. LALA A, Mentz RJ
    The Value of Community in Heart Failure.
    J Card Fail. 2025;31:1377-1378.
    >> Share


  32. Celebrate 30 Years of HFSA at ASM 2025 - Reunite, Reflect, and Reimagine the Future of Heart Failure.
    J Card Fail. 2025;31:1493-1495.
    >> Share


    J Cardiol

  33. MORI Y, Natori S, Arai T, Kakuya F, et al
    Biomarker-based pre-heart failure screening in a middle-aged rural population.
    J Cardiol. 2025 Sep 4:S0914-5087(25)00223-0. doi: 10.1016/j.jjcc.2025.
    >> Share

  34. PENG JR, Chen TH, Chen DY, Lin Y, et al
    SGLT2i with ARNi versus RASi in Heart Failure with Reduced Ejection Fraction: Improved Survival and Reduced Hyperkalemia Risk in a Real-World Cohort Study.
    J Cardiol. 2025 Sep 10:S0914-5087(25)00225-4. doi: 10.1016/j.jjcc.2025.
    >> Share


    J Cardiovasc Pharmacol

  35. HOGWOOD AC, Golino M, Moroni F, Canada JM, et al
    The Effects of Anakinra on Cardiorespiratory Fitness in Heart Failure Stratified by Age in Phase II Clinical Trials.
    J Cardiovasc Pharmacol. 2025 Sep 9. doi: 10.1097/FJC.0000000000001756.
    >> Share


    J Thorac Cardiovasc Surg

  36. DAVIES RR, Iqbal M, Lantz-Thomason J, Carrington S, et al
    Paracorporeal continuous flow ventricular assist devices (cfvads) for children < 20 kg: Challenging the paradigm in the smallest patients.
    J Thorac Cardiovasc Surg. 2025 Apr 29:S0022-5223(25)00323.
    >> Share


    PLoS One

  37. TAHA K, Ross HJ, Peikari M, Mueller B, et al
    Predicting the future risk and outcomes of severe heart failure and coronary artery disease with machine learning in the UK Biobank Cohort.
    PLoS One. 2025;20:e0329461.
    >> Share

  38. DAI L, Hu J, Yang Y, Qian B, et al
    1p-Enh-regulated CYP4B1 alleviates NNK-induced heart failure and lung cancer via the STAT3 pathway.
    PLoS One. 2025;20:e0331471.
    >> Share

  39. NENDL A, Raju SC, Braadland PR, Nordborg A, et al
    Circulating metabolites in patients with chronic heart failure are not related to gut leakage or gut dysbiosis.
    PLoS One. 2025;20:e0331692.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016